184 filings
6-K
IPHA
Innate Pharma
4 Jun 24
Innate Pharma presents positive results from TELLOMAK Phase 2 study with lacutamab in mycosis fungoides
6:03am
6-K
IPHA
Innate Pharma
28 May 24
Innate Pharma announces its participation in upcoming investor conferences
6:03am
6-K
IPHA
Innate Pharma
24 May 24
Innate Pharma Highlights Abstracts Selected For ASCO 2024 Annual Meeting
6:35am
6-K
IPHA
Innate Pharma
23 May 24
Outcome of Innate Pharma’s 2024 Annual General Meeting
4:00pm
6-K
IPHA
Innate Pharma
15 May 24
Innate Pharma Highlights Abstracts Selected For EHA 2024 Congress
6:01am
6-K
bbv0roca6 936n18
14 May 24
Innate Pharma Reports First Quarter 2024 Business Update And Financial Results
6:07am
6-K
gmb3tpphu2en
7 May 24
Innate Pharma announces conference call and webcast for Q1 2024 business update
6:03am
6-K
poulto7www
15 Apr 24
Innate Pharma Announces Advancement Of Sanofi-Developed Nk Cell Engager Sar443579 / Iph6101 Progressing To Phase 2 For Blood Cancer Patients
6:02am
6-K
bi6 ew8i49ood3
15 Apr 24
Current report (foreign)
6:00am
6-K
eej8w 5i5zpro2ih
10 Apr 24
Innate Pharma Presents at AACR 2024 Preclinical Efficacy of its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
6:51am
6-K
xioj97jzj580 bu1ea
21 Mar 24
Summary of Consolidated Financial Statements and Notes
9:20am
6-K
hfukz
21 Mar 24
Innate Pharma reports Full Year 2023 Financial Results and Business Update
6:01am
6-K
gwcen17qyr
19 Mar 24
Innate Pharma Announces Its Participation To Upcoming Investor Conference
6:33am
6-K
sf0v4nxb
14 Mar 24
Innate Pharma Announces Conference Call And Webcast For Full Year 2023 Financial Results
7:00am
6-K
i5bucg65q
6 Mar 24
Current report (foreign)
6:00am
6-K
4qrpg eoob6zkpa4fy
6 Mar 24
Current report (foreign)
6:00am
6-K
3adck4vvgkkrpc 5hc7m
21 Feb 24
Innate Pharma Announces Its Participation To Upcoming Investor Conference
6:00am
6-K
tsu6zali
6 Feb 24
Current report (foreign)
5:05pm
6-K
ylgq vxsg
12 Jan 24
Innate Pharma S.a. 6-K
6:00am
6-K
ss5tt9vex1 rp20
5 Jan 24
Innate Pharma S.a. 6-K
6:09am